IP Library Granted Patent US 7,528,261
Granted Patent B2
US 7,528,261 · App. 11/957,927 · Granted May 5, 2009

Small molecule compound having indolocarbazole moiety and divalent linkage

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,528,261
App. No.
11/957,927
Granted
May 5, 2009
Kind
B2
Abstract

A small molecule compound including at least one type of an optionally substituted indolocarbazole moiety and at least one divalent linkage.

Claims (12)

1. A small molecule compound consisting of at least one type of an indolocarbazole moiety and at least one divalent linkage,

wherein the at least one divalent linkage is independently selected from the group consisting of:

wherein the indolocarbazole moiety is independently selected from the group consisting of structures (A), (B), (C), (D), (E), (F), and (G):

wherein for each of the structures (A) through (G), each R is independently selected from a group consisting of a hydrogen, a hydrocarbon group and a heteroatom-containing group,

wherein the hydrocarbon group has from 1 to about 30 carbon atoms and is independently selected from the group consisting of: a straight chain alkyl group, a branched alkyl group, a cyclic aliphatic group, an aryl group, an alkylaryl group, and an arylalkyl group,

wherein the heteroatom-containing group is independently selected from the group consisting of: fluoroalkyl having for example 1 to about 18 carbon atoms, fluoroaryl, cyano, nitro, carbonyl, carboxylate, alkoxy having for example 1 to about 18 carbon atoms, and amino.

2. The small molecule compound of claim 1 , wherein the at least one divalent linkage consists of thienylene units.

3. The small molecule compound of claim 1 , wherein the at least one divalent linkage is conjugated.

4. The small molecule compound of claim 1 , wherein the at least one type of the indolocarbazole moiety is a plurality of indolocarbazole moieties of the same type.

5. The small molecule compound of claim 1 , wherein the number of the indolocarbazole moiety regardless of type ranges from 2 to 30; and the number of the at least one divalent linkage regardless of type ranges from 1 to 15.

6. A small molecule compound is selected from the group consisting of:

and a mixture thereof.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073842/0479 →
SECOND LIEN NOTES PATENT SECURITY AGREEMENT Recorded Jul 2, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071785/0550 →
FIRST LIEN NOTES PATENT SECURITY AGREEMENT Recorded Apr 11, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 070824/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
RELEASE OF SECURITY INTEREST IN PATENTS AT R/F 062740/0214 Recorded May 18, 2023
From: CITIBANK, N.A., AS AGENT
To: XEROX CORPORATION
Reel/Frame 063694/0122 →
SECURITY INTEREST Recorded Nov 10, 2022
From: XEROX CORPORATION
To: CITIBANK, N.A., AS AGENT
Reel/Frame 062740/0214 →